About

Your DNA, in each doctor's visit

Mendly is a U.S.-based healthcare startup headquartered in Clifton, New Jersey. We believe that many genetic diseases are misdiagnosed or diagnosed too late because genetic testing is traditionally used only as a last resort. Mendly is made possible by recent breakthroughs in whole-genome sequencing, advances in artificial intelligence, and our proprietary DNA Hyper-Sharding™ technology, which allows genomic data to be stored, processed, and accessed securely. Together, these innovations make it possible to use DNA in everyday medical decision.

Our mission is to make DNA-based precision medicine accessible, fast, and affordable.

Thiago Conrado

OUR TEAM

We are driven by innovation, efficiency, security, and transparency. These values guide how we build, operate, and partner across healthcare. We believe large-scale DNA sequencing is the next major breakthrough in medicine — enabling faster, more accurate, and more personalized care.

Thiago Conrado, PhD

Founder & CEO

Our founder is a proud father and an avid kitesurfer. He founded Mendly to help prevent other families from losing loved ones to undiagnosed genetic conditions—an experience he knows firsthand after losing his sister. He holds both a Master’s degree and a PhD in Genetics.

Jack Langberg

Co-founder & Software Developer

Jack is an avid chess player and basketball enthusiast. After managing over $100m in blockchain staking infrastructure, he joined Mendly following his grandmother's death from misdiagnosed colon cancer. He holds a degree in Computer Science with a minor in Mathematics from NYU.

Your cart is empty

Your cart

Subtotal